Skip to main content
Clinical Trials/IRCT20200411047029N2
IRCT20200411047029N2
Recruiting
N/A

The effect of pulmonary rehabilitation Mobile based application on quality of life, depression and Anxiety and activity daily living in patients Recovered of with Covid 19 undergoing pulmonary rehabilitation referred to the comprehensive respiratory clinic of Khorshid Hospital in 1400

Esfahan University of Medical Sciences0 sites38 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Esfahan University of Medical Sciences
Enrollment
38
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Declare willingness to participate in the study by completing the informed consent form
  • Age category 18\-60 years
  • Internet access and mobile phone to use mobile\-based lung rehabilitation software
  • Have a minimum literacy
  • No vision or hearing problems
  • Have the literacy to use a mobile phone to work with mobile\-based lung rehabilitation software
  • At least 21 days have elapsed since the onset of symptoms in patients with severe coronary artery disease.

Exclusion Criteria

  • Reluctance to participate in the study
  • Participate in similar courses simultaneously
  • Definitive evidence of venous and pulmonary thromboembolism
  • Acute symptoms of Covid 19 (temperature over 38 degrees ....)
  • Systolic blood pressure less than 90 mm Hg, diastolic blood pressure less than 60 mm Hg
  • Systolic blood pressure above 140 mm Hg and diastole above 90 mm Hg
  • History of heart disease class 4\-2
  • Ischemic or hemorrhagic stroke or neurodegenerative diseases
  • Major mental disorder according to psychiatrist (schizophrenia, paranoid disorders and major depression)
  • Any disorder that restricts the patient's ability to move during pulmonary rehabilitation

Outcomes

Primary Outcomes

Not specified

Similar Trials